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Prions	  and	  amyloids	  are	  often	  associated	  with	  disease,	  but	  in	  fact,	  related	  mechanisms	  19	  
provide	  beneficial	  functions	  in	  nature.	  	  Prion-­‐like	  mechanisms	  (PriLiMs)	  are	  found	  from	  bacteria	  20	  
to	  humans	  where	  they	  alter	  the	  biological	  and	  physical	  properties	  of	  prion-­‐like	  proteins.	  	  We	  21	  
have	  proposed	  that	  prions	  can	  serve	  as	  heritable	  bet-­‐hedging	  devices	  for	  diversifying	  microbial	  22	  
phenotypes.	  	  Other,	  more	  dynamic,	  proteinaceous	  complexes	  may	  be	  governed	  by	  similar	  self-­‐23	  
templating	  conformational	  switches.	  	  Additional	  PriLiMs	  continue	  to	  be	  identified	  and	  many	  24	  
share	  features	  of	  self-­‐templating	  protein	  structure	  (including	  amyloids)	  and	  dependence	  on	  25	  
chaperone	  proteins.	  	  Here	  we	  discuss	  several	  PriLiMs	  and	  their	  functions,	  intending	  to	  spur	  26	  
discussion	  and	  collaboration	  on	  the	  subject	  of	  beneficial	  prion-­‐like	  behaviors.	  27	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Glossary	  Boxes	  (Editor:	  For	  display	  in	  side	  bar.	  	  The	  first	  occurrences	  are	  bolded	  in	  the	  main	  29	  
text):	  	  30	  
	  31	  
Amyloid-­‐like	  (aməˌloid):	  	  This	  term	  is	  used	  loosely	  here	  and	  in	  the	  literature	  to	  describe	  species	  32	  
that	  1)	  might	  be	  true	  amyloids	  but	  are	  not	  yet	  fully	  characterized	  (i.e.	  not	  yet	  known	  to	  have	  33	  
cross-­‐beta	  structure),	  or	  2)	  share	  some	  amyloid	  characteristics	  but	  definitely	  not	  all	  (i.e.	  forming	  34	  
self-­‐templating	  fibers	  but	  not	  SDS-­‐resistant	  or	  Thioflavin-­‐T	  binding).	  35	  
	  36	  
PriLiM	  (prē’	  lim):	  Prion-­‐like	  mechanism.	  	  A	  phenomenon	  involving	  the	  propagation	  of	  a	  self-­‐37	  




PriLiP	  (prē’	  lip):	  Prion-­‐like	  protein.	  	  Any	  protein	  that	  can	  propagate	  its	  conformation	  via	  a	  prion-­‐40	  
like	  mechanism	  (PriLiM).	  41	  
	  42	  
Defining	  prions,	  amyloids,	  and	  similar	  phenomena	  43	  
Prions	  have	  been	  defined	  as	  “infectious	  proteins”	  that	  can	  assume	  a	  profoundly	  altered	  44	  
conformation	  and	  propagate	  that	  conformation	  in	  a	  self-­‐templating	  process.	  	  The	  mammalian	  45	  
prion	  protein,	  PrP,	  is	  the	  founding	  example	  of	  such	  self-­‐propagating	  conformations	  and	  it	  is	  the	  46	  
only	  established	  prion	  that	  is	  infectious	  to	  humans.	  	  The	  best	  characterized	  prion	  proteins	  are	  47	  
found	  in	  fungi,	  where	  their	  self-­‐propagating	  states	  are	  transmitted	  to	  mating	  partners	  and	  48	  
progeny	  as	  epigenetic	  elements	  of	  inheritance.	  A	  highly	  sophisticated	  system	  of	  remodeling	  49	  
factors	  ensures	  that	  the	  prion	  template	  is	  divided	  into	  oligomeric	  prion	  seeds	  that	  are	  inherited	  50	  
with	  very	  high	  fidelity	  [1].	  	  Most	  of	  these	  prions	  form	  an	  unusually	  stable	  aggregate	  structure	  51	  
known	  as	  an	  amyloid	  fiber,	  which	  is	  typically	  defined	  by	  three	  characteristics:	  (1)	  a	  structure	  52	  
consisting	  of	  beta	  strands	  running	  perpendicular	  to	  the	  axis	  of	  the	  fiber,	  resulting	  in	  a	  53	  
stereotypical	  cross-­‐beta	  diffraction	  pattern	  (2)	  high	  stability	  characterized	  by	  resistance	  to	  heat	  54	  
and	  SDS	  denaturation,	  and	  (3)	  binding	  to	  hydrophobic	  dyes	  such	  as	  thioflavin	  T	  and	  Congo	  55	  
Red.	  	  Owing	  to	  their	  unique	  physical	  properties,	  nature	  has	  also	  made	  extensive	  and	  diverse	  use	  56	  
of	  amyloids	  ranging	  from	  bacterial	  biofilm	  components	  to	  melanin	  scaffolding	  in	  humans	  [2–5].	  57	  
However,	  not	  all	  related	  phenomena	  fit	  squarely	  into	  the	  categories	  of	  prions	  and	  58	  
amyloids.	  	  Several	  mechanisms	  have	  been	  described	  as	  “prion-­‐like,”	  meaning	  that	  an	  initial	  59	  
4	  
	  
conformational	  change	  of	  a	  protein	  can	  template	  the	  conversion	  of	  other	  proteins	  to	  a	  similar	  60	  
or	  identical	  conformation	  [6–8].	  	  Unlike	  bona	  fide	  prions,	  these	  need	  not	  be	  transmissible	  61	  
between	  individuals.	  	  Some	  mechanisms	  have	  been	  called	  “amyloid-­‐like,”	  meaning	  that	  they	  62	  
have	  some	  but	  not	  all	  of	  the	  properties	  of	  amyloids	  [9–11].	  	  Amyloid	  and	  amyloid-­‐like	  63	  
aggregates	  are	  subsets	  of	  prion-­‐like	  phenomena	  because	  they	  template	  soluble	  proteins	  to	  64	  
adopt	  their	  fold	  as	  proteins	  are	  added	  to	  the	  aggregate.	  	  In	  this	  opinion,	  we	  illustrate	  the	  65	  
breadth	  of	  beneficial	  prion-­‐like	  mechanisms	  (PriLiMs)	  and	  their	  cognate	  prion-­‐like	  proteins	  66	  
(PriLiPs)	  by	  discussing	  several	  examples	  of	  the	  functions	  they	  provide:	  building	  stable	  67	  
structures,	  signal	  propagation,	  dynamic	  scaffolding	  of	  ribonucleoprotein	  (RNP)	  granules,	  and	  68	  
bet-­‐hedging	  in	  microorganisms.	  	  	  69	  
Bet-­‐hedging	  prions	  enhance	  phenotypic	  diversity	  and	  adaptation	  in	  microorganisms	   	  70	  
Bet-­‐hedging	  mechanisms	  are	  used	  to	  diversify	  microbial	  phenotypes.	  	  In	  fluctuating	  71	  
environments	  this	  allows	  some	  fraction	  of	  the	  population	  to	  ‘win’	  and	  thrive	  in	  conditions	  when	  72	  
most	  would	  ‘lose,’	  or	  perish	  [12],	  [13].	  	  For	  example,	  bacterial	  persister	  cells	  can	  survive	  73	  
antibiotic	  treatment,	  potentially	  saving	  the	  population	  of	  bacteria	  from	  extinction.	  	  The	  cost	  of	  74	  
this	  mechanism	  is	  that,	  until	  they	  switch	  out	  of	  their	  persistence	  phenotype,	  such	  cells	  grow	  75	  
much	  slower	  than	  normal	  cells	  in	  the	  absence	  of	  antibiotics.	  	  Even	  though	  antibiotics	  may	  be	  76	  
encountered	  rarely	  and	  persister	  cells	  have	  a	  severe	  growth	  defect,	  it	  is	  advantageous	  for	  the	  77	  
species	  to	  conserve	  this	  bet-­‐hedging	  mechanism	  to	  survive	  occasional	  exposure	  to	  such	  78	  
strenuous	  environments	  [14].	  	  	  79	  
5	  
	  
Similarly,	  we’ve	  found	  that	  fungal	  prions	  produce	  a	  variety	  of	  new	  phenotypes	  that	  are	  80	  
often	  disadvantageous	  but	  can	  provide	  great	  advantages	  in	  particular	  circumstances	  [15–19].	  	  81	  
We’ve	  proposed	  that	  such	  prions	  act	  as	  bet-­‐hedging	  mechanisms:	  	  at	  a	  low	  frequency	  in	  a	  82	  
population	  of	  yeast	  cells,	  prions	  conformations	  are	  nucleated,	  resulting	  in	  a	  heritable,	  altered	  83	  
activity	  that	  underlies	  a	  phenotypic	  change.	  	  Due	  to	  the	  self-­‐propagating	  nature	  of	  prions	  and	  to	  84	  
the	  mechanisms	  that	  ensure	  their	  orderly	  distribution	  to	  progeny,	  prion	  phenotypes	  are	  85	  
heritable.	  	  Rare	  cells,	  however,	  switch	  back	  to	  the	  non-­‐prion	  state	  when	  they	  lose	  the	  prion	  86	  
template.	  	  A	  recent	  example	  of	  a	  prion	  that	  confers	  antibiotic	  resistance	  is	  the	  yeast	  prion	  87	  
[MOD+]	  (nomenclature	  of	  yeast	  prions:	  see	  Box	  1)	  [20],	  [21].	  	  [MOD+]	  cells	  are	  resistant	  to	  azole-­‐88	  
based	  antifungals,	  but	  in	  rich	  media	  they	  have	  a	  growth	  disadvantage.	  To	  date,	  bet-­‐hedging	  89	  
functions	  for	  prions	  have	  only	  been	  described	  in	  Saccharomyces	  cerevisiae.	  However,	  many	  90	  
findings	  suggest	  they	  are	  widespread	  through	  the	  microbial	  world	  (see	  below	  and	  Box	  1)	  and	  91	  
we	  expect	  that	  more	  will	  soon	  be	  discovered	  elsewhere.	  92	  
Three	  independent	  studies	  predicted	  prion-­‐like	  sequences	  in	  the	  S.	  cerevisiae	  genome	  93	  
computationally	  [22–24],	  one	  following	  up	  with	  experimental	  evidence	  of	  prion-­‐like	  behavior	  94	  
[23].	  	  Each	  study	  identified	  sets	  of	  proteins	  that	  were	  significantly	  enriched	  for	  regulatory	  95	  
functions	  –	  transcription	  factors	  and	  RNA-­‐binding	  proteins.	  	  Importantly,	  because	  these	  96	  
proteins	  regulate	  many	  genes	  that	  often	  act	  cooperatively,	  bet-­‐hedging	  prions	  involving	  such	  97	  
factors	  could	  allow	  cells	  to	  immediately	  acquire	  complex,	  heritable	  phenotypes	  [15–17].	  	  Some	  98	  
prion	  states	  may	  confer	  “pre-­‐adapted”	  complex	  phenotypes	  to	  enhance	  survival	  in	  99	  
environments	  that	  are	  encountered	  rarely	  but	  repeatedly,	  for	  which	  bet-­‐hedging	  strategies	  are	  100	  
favored	  [12],	  [25].	  	  Other	  prions	  may	  act	  as	  evolutionary	  capacitors	  allowing	  random	  variation	  101	  
6	  
	  
to	  accumulate	  cryptically	  for	  many	  generations	  before	  being	  tested	  by	  a	  small	  proportion	  of	  the	  102	  
population	  [26].	  	  An	  example	  of	  this	  is	  the	  prion	  [PSI+],	  formed	  by	  a	  translation	  termination	  103	  
factor.	  	  The	  [PSI+]	  prion	  allows	  ribosomes	  to	  read	  through	  stop	  codons,	  uncovering	  previously-­‐104	  
silent	  genetic	  variation	  on	  a	  genome-­‐wide	  level	  [27].	  	  	  Phenotypes	  that	  provide	  a	  consistent	  105	  
advantage	  can	  become	  “fixed”	  in	  the	  genome,	  that	  is,	  independent	  of	  the	  prion,	  by	  the	  106	  
accumulation	  of	  new	  mutations	  or	  by	  the	  genetic	  reassortment	  of	  pre-­‐existing	  variation	  [18],	  107	  
[19].	  108	  
The	  phenotypes	  produced	  by	  conformational	  changes	  in	  a	  prion	  protein	  can	  be	  109	  
compared	  to	  the	  phenotypes	  that	  are	  created	  by	  genetic	  mutations	  [28],	  [29].	  	  In	  many	  cases,	  110	  
the	  prion	  conformations	  are	  self-­‐propagating	  amyloid	  states	  that	  are	  inactive,	  similar	  to	  loss-­‐of-­‐111	  
function	  or	  null	  mutations	  in	  genes.	  	  Furthermore,	  most	  prions	  can	  adopt	  multiple	  amyloid	  112	  
conformations	  with	  different	  fragmentation	  and	  elongation	  rates.	  	  These	  create	  prion	  ‘strains,’	  113	  
that	  have	  unique	  ratios	  of	  soluble:amyloid	  protein	  and	  thus	  different	  activity	  levels	  [30].	  	  These	  114	  
prion	  strains	  are	  akin	  to	  an	  allelic	  series	  of	  a	  gene,	  tuning	  the	  level	  of	  a	  protein’s	  activity,	  and	  115	  
thus	  the	  phenotypic	  consequences	  of	  the	  prion	  state	  [31].	  	  	  116	  
Depending	  on	  the	  genetic	  background	  and	  the	  particular	  prion	  protein	  involved,	  S.	  117	  
cerevisiae	  prion	  proteins	  switch	  between	  prion	  and	  non-­‐prion	  states	  at	  frequencies	  between	  118	  
10-­‐2	  and	  10-­‐7	  [31–34].	  	  Thus,	  prion-­‐based	  phenotypes	  can	  be	  sampled	  much	  more	  frequently	  on	  119	  
average	  than	  loss-­‐of-­‐function	  mutations.	  	  Furthermore,	  because	  prion	  inheritance	  depends	  on	  120	  
protein	  homeostasis	  machinery	  (see	  Box	  1),	  they	  might	  quite	  naturally	  switch	  more	  frequently	  121	  
under	  conditions	  that	  stress	  protein	  homeostasis,	  that	  is,	  when	  cells	  aren’t	  well-­‐adapted	  to	  122	  
7	  
	  
their	  environment	  (see	  Fig.	  1).	  	  This	  has	  in	  fact	  been	  observed	  for	  [PSI+]	  [32],	  [35].	  	  Increased	  123	  
switching	  under	  stress	  could	  be	  of	  great	  advantage	  to	  a	  population	  of	  yeast,	  allowing	  124	  
individuals	  to	  sample	  multiple,	  potentially	  life-­‐saving	  phenotypes	  when	  they	  most	  need	  125	  
them.	  	  This,	  in	  effect,	  changes	  the	  bets	  that	  the	  population	  of	  yeast	  has	  on	  the	  table.	  	  If	  the	  126	  
stress	  persists,	  those	  few	  cells	  that	  survive	  pass	  on	  to	  their	  progeny	  the	  protein	  state(s)	  that	  127	  
saved	  them.	  	  	  	  128	  
There	  are	  also	  cases	  where	  specific	  stresses	  induce	  specific	  prions.	  	  This	  is	  likely	  to	  occur	  129	  
for	  more	  predictable	  conditions	  that	  cells	  encounter	  regularly,	  allowing	  them	  to	  evolve	  a	  prion	  130	  
response	  which	  increases	  viability	  in	  the	  new	  environment	  (see	  Fig.	  1).	  	  Ethanol	  was	  observed	  131	  
to	  increase	  the	  appearance	  of	  the	  yeast	  prion	  [MOT3+]	  (Halfmann	  and	  Lindquist,	  unpublished	  132	  
data),	  which	  de-­‐represses	  anaerobic	  genes,	  while	  certain	  bacterial	  competitors	  could	  induce	  the	  133	  
yeast	  prion	  [GAR+]	  (Jarosz	  and	  Lindquist,	  unpublished	  data),	  which	  overcomes	  glucose	  134	  
repression.	  	  In	  both	  cases,	  [PSI+]	  is	  not	  induced,	  so	  prion	  induction	  appears	  specific,	  however	  135	  
the	  mechanisms	  of	  induction	  remain	  unknown.	  136	  
Environmental	  adaptation	  via	  bet-­‐hedging	  prions	  has	  two	  major	  advantages	  over	  137	  
adaptation	  through	  genetic	  mutation:	  (1)	  it	  allows	  a	  microbial	  population	  to	  have	  diverse,	  138	  
heritable,	  and	  complex	  responses	  to	  environmental	  conditions,	  even	  when	  the	  population	  is	  139	  
not	  large	  enough	  for	  substantial	  genetic	  diversity,	  and	  (2)	  bet-­‐hedging	  prions	  allow	  for	  fast	  140	  
reversion	  from	  a	  loss-­‐of-­‐function	  or	  “null”	  prion	  state	  of	  a	  protein,	  when	  reversion	  from	  a	  loss-­‐141	  
of-­‐function	  mutation	  at	  the	  DNA	  level	  is	  quite	  rare.	  	  	  142	  
8	  
	  
To	  exemplify	  the	  first	  point,	  a	  small	  yeast	  colony	  growing	  on	  a	  plant	  may	  gain	  benefit	  143	  
from	  having	  some	  members	  stay	  attached	  while	  others	  detach	  to	  follow	  the	  flow	  of	  rainwater	  144	  
and	  spread	  the	  population.	  Prions	  that	  regulate	  surface	  adhesion	  may	  be	  ideal	  to	  promote	  145	  
colony	  diversity.	  	  Indeed,	  a	  wild	  strain	  of	  yeast	  was	  recently	  found	  to	  adhere	  to	  agar	  growth	  146	  
medium	  after	  washing	  only	  when	  the	  translation	  termination	  factor	  Sup35	  was	  in	  its	  prion	  147	  
conformation,	  the	  [PSI+]	  state	  [19].	  	  Additionally,	  the	  FLO11	  gene	  in	  yeast,	  which	  is	  a	  central	  148	  
regulator	  of	  colony	  morphology	  and	  adhesion,	  is	  regulated	  by	  multiple	  well-­‐characterized	  yeast	  149	  
prions	  –	  URE2,	  CYC8/SSN6,	  MOT3,	  SFP1,	  and	  SWI1	  all	  affect	  its	  transcription	  [36–42].	  	  Besides	  150	  
adhesion,	  prions	  confer	  a	  number	  of	  different	  phenotypes,	  which	  vary	  from	  strain	  to	  strain,	  that	  151	  
could	  be	  used	  to	  diversify	  small	  populations.	  	  Consistent	  with	  this,	  the	  growth	  of	  [PSI+]	  and	  [psi-­‐]	  152	  
yeast	  have	  been	  compared	  across	  many	  conditions,	  and	  quite	  often	  one	  state	  or	  the	  other	  153	  
confers	  a	  marked	  benefit	  to	  growth.	  [17],	  [18],	  [35].	  	  154	  
The	  second	  advantage	  of	  bet-­‐hedging	  prions,	  the	  relatively	  fast	  rate	  of	  reversion	  from	  a	  155	  
hypomorphic	  change	  in	  activity	  due	  to	  the	  prion	  state,	  derives	  from	  the	  frequency	  at	  which	  156	  
loss-­‐of-­‐function	  mutations	  are	  beneficial	  to	  organisms.	  	  By	  far,	  the	  most	  common	  genetic	  157	  
mutations	  sampled	  are	  loss-­‐of-­‐function,	  and	  frequently	  these	  are	  adaptive.	  	  It	  may	  be	  beneficial	  158	  
to	  lose	  the	  function	  of	  a	  gene	  because	  of	  the	  energy	  cost	  associated	  with	  it	  or	  because	  new	  159	  
environmental	  conditions	  disfavor	  the	  original	  gene	  [43–45].	  	  However,	  microbial	  populations	  160	  
cannot	  adapt	  exclusively	  to	  their	  current	  environment	  at	  the	  expense	  of	  all	  others,	  because	  161	  
conditions	  in	  nature	  are	  always	  in	  flux	  (see	  Fig.	  2).	  	  Summer	  and	  winter,	  dry	  and	  wet,	  nutrient-­‐162	  
rich	  and	  nutrient-­‐poor	  conditions,	  are	  just	  a	  few	  examples	  of	  the	  cycles	  that	  many	  organisms	  163	  
must	  have	  adapted	  to	  in	  order	  to	  have	  survived	  to	  the	  present.	  	  At	  the	  same	  time,	  new	  164	  
9	  
	  
environments	  are	  also	  being	  sampled	  with	  different	  intrinsic	  physical	  properties	  and	  changing	  165	  
microbial	  competitors.	  	  S.	  cerevisiae	  was	  recently	  shown	  to	  undergo	  such	  drastic	  environment	  166	  
changes	  as	  to	  live	  on	  grapes	  in	  the	  summer	  and	  to	  survive	  the	  winter	  in	  the	  gut	  of	  wasps	  [46].	  	  A	  167	  
null	  mutation	  that	  is	  favorable	  in	  one	  environment	  could	  easily	  be	  deleterious	  in	  the	  next	  set	  of	  168	  
environments,	  which	  will	  consist	  of	  both	  familiar	  and	  novel	  elements,	  but	  genetic	  changes	  169	  
revert	  at	  a	  rather	  low	  frequency.	  	  Bet-­‐hedging	  prions	  allow	  organisms	  to	  rapidly	  acquire	  and	  170	  
revert	  from	  loss-­‐of-­‐function	  phenotypes	  and	  other	  sampled	  traits,	  testing	  new	  phenotypes	  and	  171	  
resampling	  expression	  programs	  that	  were	  advantageous	  in	  the	  past	  (see	  Fig.	  2).	  172	  
While	  bet-­‐hedging	  prions	  have	  so	  far	  only	  been	  observed	  in	  fungi,	  we	  expect	  that	  more	  173	  
will	  soon	  be	  discovered	  in	  other	  microbes.	  	  The	  first	  yeast	  prions	  identified	  in	  S.	  cerevisiae,	  174	  
Sup35	  and	  Ure2,	  have	  domains	  rich	  in	  glutamine	  and	  asparagine	  residues	  (Q/N-­‐rich	  or	  “prion-­‐175	  
like”	  domains).	  	  This	  unusual	  feature	  was	  successfully	  used	  to	  identify	  other	  S.	  cerevisiae	  176	  
proteins	  that	  could	  behave	  as	  prions	  and	  modulate	  the	  activity	  of	  a	  fused	  reporter	  [23]	  (22	  of	  177	  
the	  90	  tested	  Q/N-­‐rich	  proteins	  could	  do	  this,	  or	  24%).	  	  To	  our	  knowledge,	  no	  screen	  has	  been	  178	  
conducted	  to	  search	  for	  prion-­‐like	  domains	  in	  the	  abundance	  of	  protozoan	  genomes	  that	  have	  179	  
recently	  become	  available.	  	  In	  2000,	  Michelitsch	  and	  Weissman	  surveyed	  the	  28	  prokaryotic	  180	  
genomes	  that	  were	  available	  at	  the	  time,	  but	  found	  few	  Q/N-­‐rich	  sequences	  compared	  to	  the	  181	  
content	  of	  S.	  cerevisiae	  [22].	  	  On	  the	  other	  hand,	  an	  enormous	  24%	  of	  proteins	  in	  Plasmodium	  182	  
falciparum,	  the	  causative	  protozoan	  parasite	  of	  malaria,	  are	  Q/N-­‐rich	  [47],	  compared	  to	  1.5%	  of	  183	  
S.	  cerevisiae	  proteins,	  and	  0.3%	  of	  human	  proteins	  [22],	  [48].	  	  Furthermore,	  a	  computational	  184	  
analysis	  found	  that	  the	  propensity	  to	  form	  amyloids	  increases	  as	  organism	  complexity	  185	  
decreases	  [49],	  but	  the	  only	  single-­‐celled	  organisms	  screened	  were	  S.	  cerevisiae	  and	  186	  
10	  
	  
Paramecium	  tetraurelia,	  both	  eukaryotes.	  	  Clearly,	  a	  high-­‐throughput	  analysis	  of	  the	  thousands	  187	  
of	  microbial	  genomes	  available	  could	  provide	  a	  wealth	  of	  information	  regarding	  potential	  bet-­‐188	  
hedging	  prions.	  189	  
It	  is	  important	  to	  note,	  however,	  that	  not	  all	  yeast	  prions	  contain	  Q/N-­‐rich	  sequences.	  	  190	  
The	  Het-­‐s	  prion	  of	  the	  fungus	  Podospora	  anserina	  [50]	  and	  the	  S.	  cerevisiae	  prion	  Mod5	  [20]	  are	  191	  
both	  able	  to	  form	  amyloids	  and	  propagate	  heritably	  even	  though	  they	  lack	  any	  Q/N-­‐rich	  192	  
domain.	  	  Furthermore,	  some	  yeast	  prions	  do	  not	  form	  amyloids	  at	  all	  –	  the	  prion	  [GAR+]	  193	  
appears	  to	  consist	  of	  a	  self-­‐propagating,	  non-­‐amyloid	  interaction	  between	  two	  proteins,	  the	  194	  
proton	  pump	  Pma1	  and	  the	  glucose	  signaling	  protein	  Std1	  [51].	  	  Another	  prion,	  [β],	  consists	  of	  a	  195	  
self-­‐activating	  vacuolar	  protease	  [52].	  	  	  196	  
The	  evolutionary	  benefits	  of	  bet-­‐hedging	  prions	  are	  just	  beginning	  to	  be	  explored	  and	  197	  
remain	  controversial.	  	  An	  alternative	  hypothesis	  is	  that	  the	  ability	  of	  many	  prions	  to	  form	  198	  
amyloids	  is	  an	  undesirable	  disease	  state	  [53].	  	  Indeed,	  for	  essential	  yeast	  prion	  proteins	  like	  199	  
Sup35,	  some	  amyloid	  strains	  that	  have	  been	  generated	  by	  overexpression	  are	  so	  strong	  that	  200	  
they	  deplete	  cells	  of	  its	  essential	  activity,	  which	  kills	  them	  [54].	  	  However,	  even	  if	  this	  lethality	  201	  
occurs	  at	  natural	  expression	  levels,	  it	  could	  be	  an	  acceptable	  cost	  for	  the	  benefit	  of	  adaptability	  202	  
that	  bet-­‐hedging	  prions	  provide	  to	  the	  population	  [15],	  [16].	  	  Throughout	  evolution,	  203	  
detrimental	  mutations	  are	  experienced	  much	  more	  frequently	  than	  beneficial	  ones,	  yet	  204	  
mutations	  remain	  the	  dominant	  force	  in	  evolution.	  	  It	  is	  difficult	  to	  assess	  the	  impact	  of	  prion	  205	  
switching	  over	  the	  course	  of	  evolutionary	  history	  because	  no	  direct	  trace	  is	  left	  206	  
behind.	  	  However,	  comparative	  genomics	  may	  be	  one	  method	  of	  determining	  how	  some	  prions	  207	  
11	  
	  
have	  been	  utilized	  in	  the	  past	  [55].	  	  Others	  include	  determining	  the	  conservation	  of	  prion-­‐208	  
forming	  domains	  and	  examining	  snapshots	  of	  adapting	  cells	  recently	  taken	  from	  their	  natural	  209	  
habitat.	  	  A	  recent	  study	  surveying	  700	  wild	  S.	  cerevisiae	  isolates	  found	  that	  prions	  were	  present	  210	  
in	  at	  least	  one	  third	  of	  the	  strains	  [19].	  	  Prion	  loss	  was	  induced	  by	  transiently	  inhibiting	  a	  211	  
chaperone	  involved	  in	  maintaining	  prions.	  	  When	  assayed	  in	  12	  different	  growth	  conditions,	  212	  
prion	  loss	  frequently	  conferred	  a	  growth	  disadvantage.	  	  Thus,	  these	  prions	  had	  adaptive	  213	  
value.	  	  It	  is	  likely	  that	  these	  results	  underestimate	  the	  number	  of	  cells	  that	  are	  utilizing	  prions	  in	  214	  
natural	  populations	  because	  only	  a	  small	  number	  of	  conditions	  were	  tested.	  215	  
	  Further	  supporting	  the	  usefulness	  of	  prions	  in	  fungi,	  Medina	  and	  colleagues	  observed	  216	  
broad	  conservation	  of	  many	  prion-­‐like	  domains	  [56].	  	  The	  authors	  computationally	  searched	  217	  
through	  the	  103	  sequenced	  fungal	  genomes	  for	  homologs	  of	  29	  Q/N-­‐rich	  proteins	  that	  can	  218	  
function	  as	  prions	  in	  S.	  cerevisiae	  [23].	  	  Strikingly,	  >99%	  of	  the	  fungi	  have	  at	  least	  a	  few	  219	  
homologous	  proteins	  containing	  Q/N-­‐rich	  domains	  –	  only	  one	  distant	  relative	  lacked	  any	  such	  220	  
homolog.	  	  It	  remains	  to	  be	  shown	  whether	  these	  fungal	  prion-­‐like	  domains	  function	  as	  bet-­‐221	  
hedging	  prions,	  or	  as	  another	  kind	  of	  prion,	  or	  whether	  their	  behavior	  is	  not	  prion-­‐like	  at	  222	  
all.	  	  However,	  several	  of	  the	  Sup35	  homologs	  were	  able	  to	  propagate	  the	  [PSI+]	  prion	  in	  S.	  223	  
cerevisiae	  [57–59].	  	  It	  seems	  likely	  that	  prions	  are	  widely	  used	  as	  bet-­‐hedging	  devices	  224	  
throughout	  fungi	  and	  in	  other	  branches	  of	  life	  as	  well.	  	  225	  
Bet-­‐hedging	  strategies	  like	  this	  may	  or	  may	  not	  be	  employed	  by	  more	  complex,	  226	  
multicellular	  organisms.	  	  These	  provide	  a	  specialized	  and	  more	  stable	  environment	  (or	  niche)	  227	  
12	  
	  
for	  most	  cells	  and	  typically	  produce	  fewer	  progeny.	  	  Nevertheless,	  many	  other	  uses	  for	  PriLiMs	  228	  
have	  been	  identified,	  several	  of	  which	  we	  will	  discuss	  below.	  	  229	  
Amyloid-­‐based	  PriLiMs	  have	  useful	  physical	  properties	  230	  
Some	  prion-­‐like	  mechanisms	  (PriLiMs)	  composed	  of	  self-­‐templating	  amyloids	  are	  highly	  231	  
regulated	  and	  are	  activated	  reliably	  in	  response	  to	  particular	  signals.	  	  These	  functional	  protein	  232	  
complexes	  do	  not	  act	  as	  genetic	  elements.	  	  Some	  are	  used	  for	  the	  physical	  properties	  that	  an	  233	  
amyloid	  fiber	  provides,	  scaffolding	  meshworks,	  coating	  surfaces,	  or	  binding	  to	  pigments.	  	  These	  234	  
phenomena	  have	  been	  well-­‐reviewed	  elsewhere	  as	  types	  of	  functional	  amyloids	  [2–5],	  and	  we	  235	  
will	  only	  briefly	  mention	  their	  functions.	  236	  
In	  microorganisms,	  the	  physical	  properties	  of	  extracellular	  amyloids	  have	  been	  used	  to	  237	  
alter	  cellular	  interactions	  with	  surfaces.	  	  Diverse	  bacteria	  use	  amyloid	  fibers	  as	  a	  component	  of	  238	  
biofilms,	  which	  help	  to	  accumulate	  nutrients	  and	  protect	  bacteria	  from	  harsh	  conditions	  [60],	  239	  
[61].	  	  It	  was	  recently	  proposed	  that	  cell	  surface	  proteins	  in	  yeast	  also	  mediate	  biofilm	  240	  
attachment	  and	  function	  as	  amyloids	  [62].	  	  Both	  bacteria	  and	  fungi	  are	  able	  to	  coat	  themselves	  241	  
with	  amyloid	  fibers	  made	  of	  proteins	  called	  chaplins	  and	  class	  I	  hydrophobins,	  respectively	  [63].	  	  242	  
These	  proteins	  can	  enhance	  attachment	  of	  the	  microbe	  to	  a	  host,	  or	  allow	  it	  to	  escape	  an	  243	  
aqueous	  environment	  and	  spread	  spores	  through	  the	  air.	  	  244	  
PriLiMs	  used	  for	  their	  physical	  properties	  are	  also	  found	  in	  metazoa.	  	  Insects	  and	  fish	  245	  
use	  amyloid	  fibers	  as	  eggshell	  components	  [2].	  	  In	  humans,	  Pmel17	  forms	  amyloid	  fibers	  that	  246	  
bind	  toxic	  melanin	  precursors	  and	  scaffold	  their	  polymerization	  in	  melanosomes,	  which	  are	  247	  
subsequently	  transferred	  to	  surrounding	  cells	  [64].	  	  Recently,	  a	  variety	  of	  hormone	  peptides	  248	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were	  found	  to	  be	  stored	  in	  an	  amyloid	  state	  in	  mammalian	  pituitary	  secretory	  granules	  [65].	  	  249	  
The	  widespread	  use	  of	  these	  PriLiMs	  establishes	  amyloid	  formation	  as	  a	  common	  structural	  250	  
state	  that,	  when	  adopted,	  alters	  the	  physical	  properties	  of	  proteins.	  251	  
Stable	  PriLiMs	  as	  a	  part	  of	  biological	  signaling	  cascades	  252	  
Prion-­‐like	  aggregation	  can	  also	  alter	  biological	  activity,	  changing	  interactions	  with	  other	  253	  
macromolecules.	  	  Several	  phenomena	  have	  recently	  been	  described	  in	  which	  prion-­‐like	  254	  
aggregation	  is	  used	  to	  propagate	  a	  biological	  signal,	  providing	  a	  gain-­‐of-­‐function	  for	  the	  255	  
constituent	  protein	  or	  proteins	  (see	  Fig.	  3).	  	  	  256	  
Two	  such	  PriLiMs	  are	  involved	  in	  antiviral	  signaling.	  	  The	  first	  mechanism	  involves	  a	  257	  
templated	  conformational	  change	  of	  the	  human	  mitochondrial	  anti-­‐viral	  signaling	  (MAVS)	  258	  
protein	  on	  the	  surface	  of	  mitochondria	  to	  a	  fibrous	  state	  [6].	  	  The	  initial	  conformational	  switch	  259	  
appears	  to	  be	  templated	  by	  the	  RIG-­‐I	  protein	  when	  it	  binds	  to	  double-­‐stranded	  viral	  RNA	  in	  the	  260	  
cytoplasm.	  	  In	  its	  assembled	  form,	  MAVS	  interacts	  with	  TNF	  receptor	  associated	  factors	  (TRAFs)	  261	  
and	  propagates	  a	  signal	  that	  results	  in	  the	  induction	  of	  type	  I	  interferons	  and	  other	  antiviral	  262	  
molecules	  [6].	  	  The	  second	  mechanism	  can	  be	  triggered	  by	  Vaccinia	  virus,	  which	  inhibits	  263	  
caspases	  to	  prevent	  the	  host	  cell	  from	  undergoing	  apoptosis	  [66–68].	  	  When	  this	  happens,	  264	  
another	  cellular	  death	  mechanism	  is	  deployed.	  	  The	  cellular	  kinases	  RIP1	  and	  RIP3	  interact	  and	  265	  
rapidly	  form	  amyloid	  fibers	  [67].	  	  In	  the	  amyloid	  state,	  the	  kinase	  domains	  of	  RIP1/3	  are	  266	  
activated	  and	  phosphorylate	  downstream	  targets	  to	  cause	  programmed	  necrosis	  of	  the	  cell	  and	  267	  
an	  inflammatory	  response	  in	  the	  surrounding	  tissue	  [67],	  [69].	  	  Such	  signaling	  PriLiMs	  may	  be	  268	  
used	  at	  key	  steps	  in	  antiviral	  responses	  because	  viruses	  might	  have	  more	  difficulty	  evolving	  269	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mechanisms	  to	  interfere	  with	  self-­‐templating	  amyloid	  assembly	  than	  with	  signaling	  cascades	  270	  
which	  are	  inherently	  reversible.	  	  Such	  mechanisms	  are	  not	  likely	  to	  be	  restricted	  to	  mammals.	  271	  
Another	  signaling	  PriLiM	  is	  the	  self-­‐perpetuating	  conformation	  of	  cytoplasmic	  272	  
polyadenylation	  element	  binding	  protein	  (CPEB)	  from	  the	  neurons	  of	  the	  sea	  slug	  Aplysia.	  	  In	  its	  273	  
non-­‐prion	  state,	  CPEB	  binds	  and	  inhibits	  the	  translation	  of	  mRNAs	  that	  are	  involved	  in	  building	  274	  
stable	  synapses	  [70].	  	  The	  repeated	  stimulation	  of	  neurons	  with	  the	  learning-­‐associated	  275	  
neurotransmitter	  serotonin	  causes	  the	  assembly	  of	  CPEB	  into	  an	  amyloid	  state.	  	  CPEB	  gains	  276	  
activity	  in	  this	  form,	  enhancing	  the	  translation	  of	  target	  mRNAs.	  	  This	  plays	  a	  major	  role	  in	  277	  
strengthening	  and	  stabilizing	  synaptic	  boutons	  for	  long-­‐term	  potentiation	  [71],	  [72].	  	  The	  278	  
Drosophila	  homolog	  Orb2A	  also	  forms	  oligomers	  in	  neurons	  that	  are	  required	  for	  the	  279	  
stabilization	  of	  long-­‐term,	  but	  not	  short-­‐term	  memory.	  The	  removal	  of	  the	  prion-­‐like	  domain	  in	  280	  
Orb2A	  abolishes	  long-­‐term	  memory.	  	  Mammals	  also	  express	  several	  CPEB	  proteins	  that	  contain	  281	  
Q-­‐rich	  domains	  in	  neurons,	  but	  whether	  prion	  conversion	  contributes	  to	  memory	  in	  mammals	  is	  282	  
not	  yet	  established	  [73].	  	  Certainly,	  a	  self-­‐perpetuating	  PriLiM	  such	  as	  CPEB	  seems	  an	  ideal	  way	  283	  
to	  perpetuate	  the	  memory	  of	  stimulation	  for	  long	  periods	  of	  time,	  with	  the	  large	  size	  of	  the	  284	  
complex	  keeping	  it	  local	  and	  synapse-­‐specific.	  285	  
Astonishingly,	  when	  neuronal	  Aplysia	  CPEB	  was	  expressed	  in	  yeast,	  it	  readily	  assembled	  286	  
into	  a	  heritable,	  prion-­‐like	  state	  [7],	  [74].	  	  The	  activity	  of	  the	  CPEB	  increased	  in	  this	  prion-­‐like	  287	  
state,	  as	  it	  does	  in	  neurons,	  activating	  the	  translation	  of	  target	  mRNAs	  containing	  its	  288	  
recognition	  sequence	  –	  a	  cytoplasmic	  polyadenylation	  element.	  	  This	  demonstrates	  that	  stable	  289	  
PriLiPs	  from	  other	  organisms,	  even	  ones	  that	  are	  only	  present	  in	  differentiated,	  non-­‐dividing	  290	  
15	  
	  
cells,	  can	  be	  propagated	  indefinitely	  as	  prions	  in	  yeast.	  	  Using	  yeast	  as	  a	  model	  for	  these	  291	  
mechanisms	  could	  be	  of	  great	  advantage	  for	  studying	  phenomena	  from	  less	  genetically-­‐292	  
tractable	  organisms.	  	  293	  
Like	  Aplysia	  CPEB,	  some	  endogenous	  yeast	  prions	  may	  have	  altered	  function,	  rather	  294	  
than	  simply	  decreased	  function,	  in	  the	  prion	  state.	  	  The	  [ISP+]	  prion	  does	  not	  confer	  the	  same	  295	  
phenotypes	  found	  in	  a	  Δsfp1	  strains,	  but	  rather	  the	  additional	  phenotype	  of	  nonsense	  296	  
antisuppression	  [75].	  	  	  297	  
It	  is	  unlikely	  that	  stable	  PriLiMs	  are	  used	  exclusively	  for	  either	  their	  physical	  properties	  298	  
or	  for	  signaling,	  but	  rather	  for	  a	  combination	  of	  both.	  	  An	  interesting	  avenue	  for	  future	  research	  299	  
is	  to	  determine	  how	  the	  physical	  structure	  of	  amyloids	  may	  help	  to	  scaffold	  the	  interactions	  of	  300	  
signaling	  PriLiPs,	  and	  how	  amyloids	  that	  are	  used	  for	  their	  physical	  properties,	  such	  as	  CsgA	  in	  301	  
biofilms,	  may	  alter	  their	  interactions	  with	  binding	  partners	  upon	  assembly.	  	  	  	  	  302	  
Dynamic	  PriLiMs	  help	  to	  form	  reversible	  RNP	  granules	  303	  
Prion-­‐like	  domains	  are	  also	  involved	  in	  the	  assembly	  of	  dynamic	  ribonucleoprotein	  304	  
(RNP)	  granules	  that	  process	  and	  modify	  RNA.	  	  While	  it	  has	  been	  known	  for	  some	  time	  that	  Q/N-­‐305	  
rich,	  Q-­‐rich,	  or	  other	  low	  complexity	  domains	  are	  essential	  for	  forming	  some	  RNP	  granules	  [8],	  306	  
[76],	  [77],	  how	  these	  large	  assemblies	  are	  regulated	  and	  structured	  remains	  elusive.	  	  Unlike	  307	  
amyloids,	  stress	  granules	  are	  composed	  of	  many	  different	  proteins	  which	  can	  undergo	  rapid	  308	  
exchange	  with	  the	  cytoplasm	  [76],	  [78].	  	  Recently,	  a	  clue	  to	  this	  puzzle	  was	  found	  by	  Han,	  Kato,	  309	  
and	  colleagues.	  	  Even	  with	  no	  RNA	  present,	  many	  RNPs	  could	  be	  precipitated	  together	  from	  310	  
mammalian	  cell	  extracts	  using	  a	  crystalline	  compound	  that	  is	  thought	  to	  mimic	  the	  surface	  of	  a	  311	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cross-­‐beta	  sheet	  [9],	  [79].	  	  The	  retention	  of	  GFP-­‐tagged	  protein	  in	  a	  hydrogel	  composed	  of	  the	  312	  
RNA-­‐binding	  protein	  FUS	  provided	  an	  in	  vitro	  assay	  for	  interactions	  between	  these	  low-­‐313	  
complexity	  sequences.	  	  The	  FUS	  fibers	  comprising	  the	  hydrogels	  were	  amyloid-­‐like	  as	  assessed	  314	  
by	  their	  stereotypical	  diffraction	  pattern	  and	  appearance	  by	  electron	  microscopy.	  	  But	  unlike	  315	  
amyloids,	  these	  assemblies	  could	  incorporate	  different	  proteins,	  were	  rapidly	  reversible,	  and	  316	  
were	  not	  SDS-­‐resistant.	  	  Thus,	  concerted,	  templated	  conformational	  changes	  among	  different	  317	  
low-­‐complexity	  domains	  could	  be	  the	  basis	  of	  RNP	  granule	  formation.	  	  	  318	  
Such	  a	  mechanism	  is	  prion-­‐like	  in	  that	  one	  protein	  templates	  another	  to	  fold	  into	  the	  319	  
same	  basic	  structure,	  but	  is	  different	  from	  other	  PriLiMs	  because	  it	  is	  much	  more	  dynamic,	  320	  
perhaps	  allowing	  the	  segregation	  of	  interacting	  domains	  into	  a	  ‘liquid’	  or	  gel-­‐like	  phase	  321	  
separated	  from	  the	  rest	  of	  the	  cytosol	  [80],	  [81].	  	  Phosphorylated	  FUS	  monomers	  no	  longer	  322	  
interact	  with	  the	  assembled	  FUS	  hydrogel,	  suggesting	  that	  assembly	  could	  be	  regulated	  by	  post-­‐323	  
translational	  modification	  [79].	  	  324	  
A	  screen	  of	  Q/N-­‐rich	  domains	  in	  yeast	  identified	  several	  RNP	  granule	  components	  with	  325	  
domains	  that	  could	  act	  as	  yeast	  prions,	  and	  perhaps	  have	  bet-­‐hedging	  functions	  [23],	  [82].	  	  326	  
Nrp1,	  Pub1,	  and	  Hrp1,	  which	  associate	  with	  yeast	  stress	  granules,	  and	  Lsm4,	  which	  contributes	  327	  
to	  P	  body	  formation,	  could	  all	  form	  amyloid	  fibers	  and	  propagate	  the	  activity	  state	  of	  a	  fused	  328	  
reporter	  [23].	  	  Notably,	  like	  FUS	  fibers,	  Hrp1	  fibers	  were	  not	  SDS-­‐resistant.	  	  The	  physical	  state	  of	  329	  
these	  yeast	  proteins	  in	  such	  RNP	  granules	  remains	  to	  be	  determined,	  but	  they	  may	  well	  330	  
assemble	  in	  a	  dynamic	  fashion.	  	  If,	  instead	  of	  forming	  such	  reversible	  assemblies,	  a	  small	  331	  
17	  
	  
fraction	  of	  the	  population	  inactivates	  these	  RNA	  binding	  proteins	  by	  nucleating	  an	  amyloid,	  it	  332	  
might	  serve	  as	  a	  bet-­‐hedging	  mechanism	  to	  diversify	  cellular	  phenotypes	  	  333	  
RNP	  granules	  are	  found	  broadly	  throughout	  eukaryotes	  –	  some	  regulate	  RNAs	  334	  
spatiotemporally	  in	  gametes	  and	  embryos,	  while	  others	  are	  used	  to	  transport	  RNA	  down	  335	  
neuronal	  dendrites	  [78].	  	  How	  these	  dynamic	  complexes	  are	  assembled	  and	  regulated	  in	  vivo	  at	  336	  
a	  molecular	  level	  is	  still	  largely	  unknown,	  and	  will	  be	  a	  fascinating	  avenue	  of	  future	  research.	  337	  
Concluding	  remarks	  338	  
We	  have	  discussed	  several	  biological	  functions	  that	  prion-­‐like	  mechanisms	  (PriLiMs)	  339	  
have	  in	  nature.	  	  It	  is	  likely	  that	  many	  more	  PriLiMs	  await	  discovery	  in	  diverse	  cellular	  340	  
pathways.	  	  In	  C.	  elegans,	  1%	  of	  proteins	  have	  Q/N-­‐rich,	  prion-­‐like	  domains,	  and	  in	  Drosophila	  341	  
the	  fraction	  is	  even	  greater,	  3.5%	  [22].	  	  Some	  might	  function	  as	  stable	  or	  dynamic	  PriLiMs,	  and	  a	  342	  
small	  number	  may	  even	  have	  bet-­‐hedging	  functions.	  	  The	  yeast	  prions	  [GAR+],	  [Het-­‐s],	  and	  343	  
[MOD+]	  demonstrate	  that	  even	  proteins	  without	  canonical	  prion-­‐like	  domains	  can	  function	  as	  344	  
prions.	  	  The	  real	  number	  of	  self-­‐templating	  PriLiMs	  functioning	  in	  nature	  may	  be	  much	  greater	  345	  
than	  we	  can	  currently	  predict	  by	  sequence.	  346	  
Despite	  the	  diversity	  of	  PriLiMs,	  some	  basic	  principles	  are	  likely	  to	  be	  shared.	  	  For	  347	  
example,	  they	  may	  all	  take	  advantage	  of	  the	  cells	  core	  protein	  homeostasis	  machinery.	  	  The	  S.	  348	  
cerevisiae	  prion	  proteins	  investigated	  to	  date	  all	  depend	  on	  Hsp104	  and/or	  Hsp70	  [20],	  [23],	  349	  
[48],	  [51],	  [83].	  	  MAVS	  aggregation	  in	  extracts	  from	  human	  cells	  appears	  to	  be	  dependent	  on	  350	  
Hsp90	  [6],	  and	  mammalian	  stress	  granule	  regulation	  involves	  Hsp70	  and	  perhaps	  other	  351	  
chaperones	  [8].	  	  Aplysia	  CPEB	  is	  readily	  propagated	  in	  yeast	  where	  it	  forms	  a	  yeast	  prion,	  and	  is	  352	  
18	  
	  
also	  subject	  to	  chaperone	  activity	  [7].	  	  These	  connections	  to	  protein	  homeostasis	  may	  make	  353	  
them	  intrinsically	  responsive	  to	  diverse	  internal	  and	  extracellular	  conditions.	  	  This,	  however,	  is	  354	  
clear:	  prion-­‐like	  mechanisms	  are	  not	  restricted	  to	  disease,	  but	  are	  broadly	  used	  for	  the	  benefit	  355	  
















Box	  1:	  Yeast	  prions	  confer	  non-­‐Mendelian	  traits	  and	  depend	  on	  chaperones	  to	  propagate	  370	  
In	  1994,	  prion	  propagation	  was	  proposed	  to	  explain	  some	  perplexing,	  non-­‐Mendelian	  371	  
phenotypes	  identified	  in	  yeast	  [84].	  	  A	  yeast	  prion	  segregates	  in	  a	  non-­‐Mendelian	  fashion	  372	  
because	  it	  is	  not	  based	  on	  a	  mutation	  in	  DNA	  inherited	  through	  chromosomes,	  but	  rather	  on	  a	  373	  
self-­‐propagating	  protein	  conformation	  inherited	  through	  the	  cytosol.	  	  If	  a	  cell	  containing	  the	  374	  
prion	  state	  of	  a	  protein	  (a	  [PRION+]	  cell)	  mates	  with	  a	  cell	  containing	  that	  protein	  in	  a	  nonprion	  375	  
state	  (a	  [prion-­‐]	  cell),	  the	  nonprion	  proteins	  are	  rapidly	  templated	  and	  take	  on	  the	  self-­‐376	  
propagating	  prion	  conformation.	  	  	  Because	  all	  meiotic	  progeny	  inherit	  part	  of	  the	  parental	  377	  
cytosol,	  the	  vast	  majority	  will	  display	  the	  prion	  phenotype,	  rather	  than	  50%,	  as	  one	  might	  have	  378	  
expected	  if	  the	  phenotypes	  were	  based	  on	  two	  different	  alleles	  of	  a	  gene.	  	  We	  refer	  the	  379	  
interested	  reader	  to	  these	  excellent	  reviews	  on	  yeast	  prion	  biology	  [31],	  [85],	  [86].	  380	  
The	  [PRION+]	  /	  [prion-­‐]	  nomenclature	  is	  used	  for	  all	  yeast	  prions	  -­‐	  square	  brackets	  381	  
indicate	  the	  non-­‐Mendelian	  segregation	  of	  the	  prion	  phenotype;	  capital	  letters	  indicate	  the	  382	  
dominant	  phenotype	  in	  mating	  (the	  self-­‐propagating	  conformational	  change),	  while	  lower-­‐case	  383	  
letters	  designate	  the	  recessive	  phenotype	  usually	  associated	  with	  soluble,	  un-­‐templated	  384	  
protein.	  385	  
	   Chaperones	  are	  intimately	  involved	  in	  prion	  propagation	  –	  perturbing	  chaperone	  386	  
function	  often	  results	  in	  an	  increased	  rate	  of	  prion	  appearance	  or	  loss	  (or	  both)	  [31],	  [35],	  [87].	  	  387	  
The	  majority	  of	  fungal	  prions	  rely	  on	  Hsp104	  [20],	  [23],	  a	  protein	  disaggregase	  that	  can	  sever	  388	  
amyloid	  fibers	  and	  generate	  new	  ends	  for	  growth	  [87].	  	  By	  inhibiting	  this	  enzyme	  over	  several	  389	  
generations,	  [prion-­‐]	  cells	  can	  be	  reliably	  generated	  from	  a	  [PRION+]	  population	  [88].	  	  Hsp104	  390	  
20	  
	  
cooperates	  with	  Hsp70	  and	  Hsp40	  to	  exert	  this	  prion-­‐propagating	  activity	  in	  a	  delicately	  391	  
balanced	  process	  that	  seems	  to	  have	  been	  fine-­‐tuned	  to	  allow	  for	  prion	  propagation	  [87].	  	  One	  392	  
prion,	  [GAR+],	  does	  not	  appear	  to	  result	  from	  an	  amyloid	  conformation	  and	  is	  not	  dependent	  on	  393	  
Hsp104,	  but	  still	  requires	  Hsp70	  to	  propagate	  into	  daughter	  cells	  [51].	  	  	  	  394	  
	   Homologues	  of	  all	  of	  these	  chaperones	  are	  found	  broadly	  throughout	  many	  branches	  of	  395	  
life,	  perhaps	  indicating	  a	  conserved	  ability	  to	  propagate	  prions.	  	  Bacterial	  homologs	  were	  396	  
recently	  found	  to	  be	  capable	  of	  replacing	  yeast	  chaperones	  to	  propagate	  a	  prion	  in	  yeast	  [89],	  397	  
and	  yeast	  prions	  have	  been	  successfully	  nucleated	  in	  the	  bacterial	  cytoplasm	  [90].	  	  Flies,	  398	  
worms,	  and	  plants	  also	  have	  Hsp104	  homologs	  –	  it	  will	  be	  interesting	  to	  see	  whether	  these	  are	  399	  
also	  capable	  of	  propagating	  yeast	  prions	  or	  their	  own,	  endogenous	  PriLiPs.	  	  Mammals	  have	  no	  400	  
Hsp104	  homolog	  and	  had	  been	  thought	  to	  lack	  disaggregase	  machinery,	  but	  recently	  Hsp110	  401	  
has	  been	  shown	  to	  cooperate	  with	  Hsp70	  and	  Hsp40	  to	  this	  effect	  [91].	  	  While	  the	  mammalian	  402	  
machinery	  was	  not	  able	  to	  remodel	  the	  yeast	  prion	  Sup35,	  it	  may	  yet	  have	  similar	  activity	  for	  403	  
PriLiMs	  in	  its	  native	  cellular	  context.	  404	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Figure	  Legends:	  686	  
Figure	  1.	  	  Hypothesis:	  Bet-­‐hedging	  prions	  ( , ,	   )	  are	  adaptive	  and	  can	  respond	  to	  687	  
stress.	  	  688	  
Yeast	  prion	  states	  provide	  advantages	  in	  a	  variety	  of	  environments	  [17],	  [18],	  and	  prion	  689	  
switching	  increases	  in	  response	  to	  environmental	  stress	  [35].	  	  Two	  types	  of	  prion-­‐switching	  690	  
induction	  are	  proposed	  –	  stochastic	  and	  specific.	  	  The	  “blue	  environment”	  signifies	  691	  
unpredictable	  environmental	  stresses	  in	  which	  prions	  are	  induced	  stochastically.	  	  This	  might	  be	  692	  
observed	  for	  any	  stress	  that	  significantly	  perturbs	  protein	  homeostasis	  and	  stresses	  the	  693	  
chaperone	  machinery	  involved	  in	  maintaining	  prion	  states.	  	  Note	  that	  each	  different	  prion	  694	  
causes	  a	  different	  phenotype,	  indicated	  by	  the	  color	  of	  the	  cell.	  	  After	  competition,	  a	  prion	  state	  695	  
that	  proved	  advantageous	  dominates	  the	  population	  of	  cells.	  	  The	  “green	  environment”	  696	  
signifies	  an	  environmental	  stress	  that	  induces	  a	  specific	  prion	  pre-­‐adapted	  to	  enhance	  survival	  697	  
in	  that	  condition.	  	  This	  is	  more	  likely	  to	  occur	  for	  stresses	  that	  are	  encountered	  regularly	  698	  
throughout	  the	  evolution	  of	  the	  organism.	  	  Specific	  prion	  induction	  has	  been	  observed	  for	  699	  
[MOT3+]	  in	  ethanol	  (Halfmann	  and	  Lindquist,	  unpublished	  data),	  and	  for	  [GAR+]	  in	  the	  presence	  700	  
of	  bacterial	  competitors	  (Jarosz	  and	  Lindquist,	  unpublished	  data).	  	  Note	  that	  there	  will	  generally	  701	  







Figure	  2.	  	  Hypothesis:	  Bet-­‐hedging	  prions	  allow	  rapid	  phenotypic	  diversification,	  acquisition	  707	  
of	  complex	  traits,	  and	  facile	  reversion	  to	  previous	  phenotypes	  	  708	  
(A)	  Different	  combinations	  of	  prion/non-­‐prion	  conformations	  amongst	  many	  available	  prion	  709	  
proteins	  allow	  shuffling	  of	  heritable	  phenotypes.	  	  The	  red	  and	  blue	  cells	  indicate	  two	  possible	  710	  
combinations	  of	  prions,	  and	  thus	  heritable	  phenotypes,	  between	  genetically	  identical	  cells	  in	  a	  711	  
population.	  	  A	  cell	  will	  switch	  to	  a	  new	  prion	  state	  at	  a	  rather	  low	  frequency.	  	  Thus,	  it	  is	  possible	  712	  
to	  generate	  new	  combinations	  of	  prion	  states	  that	  are	  not	  present	  or	  may	  have	  previously	  died	  713	  
out.	  714	  
(B)	  Cells	  experience	  slowly-­‐oscillating	  environments	  and	  may	  benefit	  from	  resampling	  715	  
phenotypes	  that	  were	  advantageous	  in	  the	  past.	  	  Adaptations	  made	  through	  bet-­‐hedging	  prions	  716	  
are	  reversed	  more	  frequently	  than	  are	  mutations.	  	  This	  could	  allow	  cells	  to	  adapt	  to	  previously-­‐717	  
encountered	  environments	  more	  quickly.	  718	  
(C)	  Cells	  frequently	  sample	  new,	  complex	  environments,	  for	  example	  as	  different	  microbial	  719	  
competitors	  and	  surfaces	  are	  encountered.	  	  Shuffling	  the	  states	  of	  multiple	  prion	  proteins	  720	  
(indicated	  by	  different	  yeast	  cell	  colors)	  allows	  rapid	  phenotypic	  diversification	  enhancing	  the	  721	  
likelihood	  that	  some	  members	  of	  the	  population	  will	  adapt	  and	  survive	  each	  new	  environment.	  	  722	  
Here,	  the	  yeast	  sample	  environments	  progressing	  from	  leaf,	  to	  fruit,	  to	  insect,	  to	  liquid	  culture,	  723	  
each	  with	  its	  own	  set	  of	  microfauna,	  and	  different	  prion	  states	  dominate	  the	  population	  in	  each	  724	  
environment.	  	  In	  the	  next,	  unknown	  environment	  another	  combination	  of	  prion	  states	  may	  be	  725	  
advantageous.	  	  Many	  prion	  combinations	  may	  be	  present	  at	  a	  low	  frequency	  in	  the	  population	  726	  
prior	  to	  entering	  the	  environment,	  and	  the	  stresses	  of	  a	  new	  environment	  may	  induce	  727	  
additional	  prion	  switching	  to	  enhance	  adaptation.	  728	  
32	  
	  
Figure	  3.	  	  PriLiMs	  can	  alter	  the	  biological	  properties	  of	  a	  protein.	  	  	  729	  
(A)	  Prion-­‐like	  assemblies	  may	  alter	  protein-­‐protein	  interactions.	  	  Mitochondrial	  antiviral	  730	  
signaling	  protein	  (MAVS),	  on	  the	  surface	  of	  mitochondria,	  interacts	  with	  TNF	  receptor-­‐731	  
associated	  factors	  (TRAFs)	  after	  prion-­‐like	  aggregation	  [6].	  	  732	  
(B)	  Other	  proteins	  gain	  catalytic	  function	  when	  they	  assemble	  into	  amyloid.	  	  Here,	  RIP1	  and	  733	  
RIP3	  are	  depicted	  as	  inactive	  kinases	  that	  are	  activated	  upon	  assembly.	  	  This	  activity	  is	  thought	  734	  
to	  be	  in	  part	  due	  to	  enhanced	  auto-­‐	  and	  cross-­‐phosphorylation	  in	  the	  assembled	  form,	  which	  is	  735	  
prevented	  by	  other	  factors	  before	  assembly	  [67],	  [68].	  	  The	  kinase	  image	  was	  adapted	  from	  736	  
PDB	  entry	  2J2I	  for	  purely	  illustrative	  purposes.	  	  	  737	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